Approval · Notice of Compliance 354 · 2002
CILOXAN: Notice of Compliance 354
Issued June 13, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 354
- Date
- June 13, 2002
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: acute otitis externa; new route of administration: otic
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CILOXAN | 01945270 | Marketed |
Medicinal ingredients
- CIPROFLOXACIN HYDROCHLORIDE 0.3 PER